The impacts of the COVID-19 pandemic on patients with viral hepatitis B infection: follow-up, compliance with antiviral treatment, and vaccine preferences
CONCLUSIONS: It was reported that elimination programs and interventions for HBV infection decreased or stopped because of the COVID-19 pandemic. In the present study, no newly diagnosed case of HBV infection was detected. Most of the patients had their follow-up visits disrupted. There were no patients who could not receive antiviral treatment, the vaccination rate of the patients was high, and the vaccines were well tolerated.PMID:37318505 | DOI:10.26355/eurrev_202306_32650
Source: Pharmacological Reviews - Category: Drugs & Pharmacology Authors: B Ozdemir A Altunsoy E Akinci R Guner Source Type: research
More News: Covid Vaccine | COVID-19 | Drugs & Pharmacology | Hepatitis | Hepatitis B | Hepatitis Vaccine | Liver | Pandemics | Pfizer | Statistics | Study | Urology & Nephrology | Vaccines